DB19095InvestigationalCell transplant therapies
Elivaldogene tavalentivec: Overview.
- Also known as
- A vsv-g*-pseudotyped self-inactivating hiv-1-derived lentiviral vector (plbp100 hald) encoding human adrenoleukodystrophy (ald) protein (abcd1 gene) under the control of a modified myeloproliferative sarcoma virus promoter · Dna (lentiviral vector clone lenti-d human x-linked adrenoleukodystrophy abcd1 gene cdna-specifying) · Lenti-d · Lenti-d drug product
Resolves to
Compound
What you can answer from here — as of September 25, 2025
Which companies are running trials of Elivaldogene tavalentivec, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account